Stockreport

INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update

INmune Bio Inc. - Common stock  (INMB) 
PDF BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on dev [Read more]